Clinical efficacy of the rotation of phototherapy methods (PUVA therapy and mid-wavelength ultraviolet therapy (311 nm)) in patients with moderate to severe forms of psoriasis
暂无分享,去创建一个
[1] L. Misery,et al. Efficacy of Psoralen UV‐A therapy vs. Narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.
[2] T. Tsai,et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. , 2011, Journal of dermatological science.
[3] H. Hönigsmann,et al. Failure of short‐term psoralen and ultraviolet A light maintenance treatment to prevent early relapse in patients with chronic recurring plaque‐type psoriasis , 2009, Photodermatology, photoimmunology & photomedicine.
[4] A. de Silvestri,et al. The Duration of Clinical Remission of Photochemotherapy and Narrow-Band UV-B Phototherapy in the Treatment of Psoriasis: A Retrospective Study , 2008, International journal of immunopathology and pharmacology.
[5] Consuelo Huerta,et al. Incidence and risk factors for psoriasis in the general population. , 2007, Archives of dermatology.
[6] J. Hawk,et al. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. , 2006, Archives of dermatology.
[7] Michael W. Taylor,et al. Coincidence of immune‐mediated diseases driven by Th1 and Th 2 subsets suggests a common aetiology. A population‐based study using computerized General Practice data , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[8] S. Puig,et al. Prevalence of psoriasis in Spain (Epiderma Project: phase I) , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.
[9] J. Ferguson,et al. 8‐MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose‐based regimen with a skin‐type approach , 1996, The British journal of dermatology.
[10] C. Patterson,et al. Cutaneous neoplasia following PUVA therapy for psoriasis , 1996, The British journal of dermatology.
[11] P. Kullavanijaya,et al. Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA , 1995, Photodermatology, photoimmunology & photomedicine.
[12] P. Farr,et al. Skin cancers or premalignant lesions occur in half of high‐dose PUVA patients , 1994, The British journal of dermatology.
[13] B. Berne,et al. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report. , 1992, Archives of dermatology.
[14] J. Parrish,et al. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. , 1977, The Journal of investigative dermatology.
[15] K. Gordon,et al. Comparative Tolerability of Systemic Treatments for Plaque-Type Psoriasis , 2002, Drug safety.
[16] M. Schemper,et al. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. , 1996, Dermatology.